News 

August 28, 2017. Congratulations to Dr. Shuyun Dong and Peng Zhao for their recent three publications in Molecular Pharmaceutics and  Acta Pharmacologica Sinica. These publications summarized recent progress in our lab in development carriers for immunotherapeutics including vaccines and antibody drugs. 

                                                                                                                                                                                                                          

March 29, 2017.  Congratulations to Peng Zhao for being selected as a 2017-2018 University of Utah Graduate Research Fellow. What an achievement! He will use the fellowship support to explore better immunotherapeutics.

                                                                                                                                                                                                                         

March, 2017.  We received an R21 funding support to explore new approaches to directly load CTL vaccine epitopes  onto MHC class I complex on dendritic cell surfaces. These approaches promise to skip those inefficient intracellular vaccine processing steps in dendritic cells and hence improve the efficacy of CTL vaccines. 

                                                                                                                                                           

April 2016.  Dr. Mingnan Chen and Peng Zhao shared their passion, accomplishments, and future plans of using vaccines and iTEP vaccine carriers to fight cancer and infectious diseases on The Scope, the University of Utah Health Sciences Radio. Turn on your speaker! 
                                                                                                                                                                                                                           April 25, 2016. Peng Zhao won the Fox Award! The Jeffery Fox Award recognizes a graduate student of Utah Pharmaceutics yearly for his or her excellence in academic achievements and services to the department. This award was established to honor Dr. Jeffery Fox for his dedication and care to the department. Peng was selected for exemplifying the spirit of Jeffery Fox. Way to go, Peng!                                                                                                                                                                                                                                                             

 April 6, 2016. Congratulations to Peng Zhao and Dr. Shuyun Dong! Their co-authored manuscript, entitled "An iTEP-salinomycin nanoparticle that specifically and effectively inhibits metastases of 4T1 orthotopic breast tumors" was published online by Biomaterials .  Here is a linker for the PDF document of the paper. We are thankful to our collaborators Mr. Guiquan Xia and Dr. Zhong-xing Jiang. We also appreciate technical and equipment supports from Professor Jindrich (Henry) Kopecek's and Sung Wan Kim's  groups.

                                                                                                                                                           

Februa​ry 29, 2016. Peng Wang presented his research at the department seminar, which was well-received. Here is a flyer of his seminar entitled "Multifunctional vaccine carrier enhancing immune response”. 

                                                                                                                                                           
February 8, 2016. Congratulations to Dr. Shuyun Dong! Dr. Dong's manuscript, entitled "A comparison study of iTEP nanoparticle-based CTL vaccine carriers revealed a surprise relationship between the stability and efficiency of the carriers," was accepted for publication by Theranostics.  DOI: 10.7150/thon.14068. 



Chen Lab, Department of Pharmaceutics & Pharmaceutical Chemistry, University of Utah

30 South 2000 East, Salt Lake City, Utah 84112 USA

Chen's Laboratory for Immunotherapeutic Study

OF

UNIVERSITY  OF  UTAH     Department  of  Pharmaceutics

COLLEGE    PHARMACY    and Pharmaceutical Chemistry